Pricing Log in Create free account

Clinuvel Pharmaceuticals Ltd. - Sponsored ADR (CUVL) vs ARS Pharmaceuticals, Inc. (SPRY)

Clinuvel Pharmaceuticals Ltd. - Sponsored ADR and ARS Pharmaceuticals, Inc. are both Biotechnology companies. Clinuvel Pharmaceuticals Ltd. - Sponsored ADR and ARS Pharmaceuticals, Inc. are of similar size ($280.5M and $257.5M).

Valuation

Metric CUVL SPRY Biotechnology median
P/E — n/m 10.60
P/S — 2.28 9.40
P/B — n/m 2.13
Price to free cash flow — n/m 25.18
EV/EBITDA — n/m 0.66
EV/Sales — 2.55 9.02
Earnings yield — (72.40%) (32.88%)
Free cash flow yield — (71.47%) (23.13%)

Profitability

Metric CUVL SPRY Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin — (161.50%) 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin — (149.89%) 0.00%
Return on equity — 0.00% (51.96%)
Return on assets — 0.00% (46.06%)
Return on invested capital — 0.00% 0.00%

Growth

Metric CUVL SPRY Biotechnology median
Revenue growth (TTM) — (14.45%) 6.76%
EPS growth (last fiscal year) — (2,275.00%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CUVL SPRY Biotechnology median
Debt to equity — 0.00 0.00
Current ratio — 3.25 4.97
Net debt to EBITDA — 0.42 1.01

Dividend

Metric CUVL SPRY Biotechnology median
Dividend yield 0.56% — 0.41%
Payout ratio — — —

Size

Metric CUVL SPRY Biotechnology median
Market cap 257.50m 280.47m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack